209 related articles for article (PubMed ID: 35709153)
1. Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis.
Xu W; Zhang M; Liu L; Yin M; Xu C; Weng Z
PLoS One; 2022; 17(6):e0269612. PubMed ID: 35709153
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of the diagnostic role of mucin family members in pancreatic cancer: a meta-analysis.
Wang S; You L; Dai M; Zhao Y
Ann Transl Med; 2021 Feb; 9(3):192. PubMed ID: 33708819
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis.
Li B; Tang H; Zhang A; Dong J
PLoS One; 2016; 11(6):e0157878. PubMed ID: 27305093
[TBL] [Abstract][Full Text] [Related]
4. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
Yonezawa S; Sato E
Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of the neutrophil-to-lymphocyte ratio in the prognosis and risk of death for adult sepsis patients: a meta-analysis.
Wu H; Cao T; Ji T; Luo Y; Huang J; Ma K
Front Immunol; 2024; 15():1336456. PubMed ID: 38562922
[TBL] [Abstract][Full Text] [Related]
6. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
7. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
[TBL] [Abstract][Full Text] [Related]
8. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
[TBL] [Abstract][Full Text] [Related]
9. Rationale and feasibility of mucin expression profiling by qRT-PCR as diagnostic biomarkers in cytology specimens of pancreatic cancer.
Wiktorowicz M; Mlynarski D; Pach R; Tomaszewska R; Kulig J; Richter P; Sierzega M
Pancreatology; 2018 Dec; 18(8):977-982. PubMed ID: 30268674
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of lymph node ratio for thyroid cancer: a meta-analysis.
Hu Y; Wang Z; Dong L; Zhang L; Xiuyang L
Front Oncol; 2024; 14():1333094. PubMed ID: 38384804
[TBL] [Abstract][Full Text] [Related]
11. Prognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis.
Ruys AT; Groot Koerkamp B; Wiggers JK; Klümpen HJ; ten Kate FJ; van Gulik TM
Ann Surg Oncol; 2014 Feb; 21(2):487-500. PubMed ID: 24081803
[TBL] [Abstract][Full Text] [Related]
12. Significance of mucin expression in pancreatobiliary neoplasms.
Yonezawa S; Higashi M; Yamada N; Yokoyama S; Goto M
J Hepatobiliary Pancreat Sci; 2010 Mar; 17(2):108-24. PubMed ID: 19787286
[TBL] [Abstract][Full Text] [Related]
13. The VEGF expression associated with prognosis in patients with intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
Cai C; Wang X; Fu Q; Chen A
World J Surg Oncol; 2022 Feb; 20(1):40. PubMed ID: 35189920
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis.
Chen X; Liang R; Lai L; Chen K; Zhu X
Front Oncol; 2021; 11():697369. PubMed ID: 34490092
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.
Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA
Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771
[TBL] [Abstract][Full Text] [Related]
16. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
[No Abstract] [Full Text] [Related]
17. Mucin Expression and Splicing Determine Novel Subtypes and Patient Mortality in Pancreatic Ductal Adenocarcinoma.
Thompson CM; Cannon A; West S; Ghersi D; Atri P; Bhatia R; Smith L; Rachagani S; Wichman C; Kumar S; Batra SK
Clin Cancer Res; 2021 Dec; 27(24):6787-6799. PubMed ID: 34615717
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of B7H1 and B7H4 expression in pancreatic cancer: A meta-analysis.
Qi ZJ; Yu D; Chen CH; Jiang H; Li R; Kang YM
Int J Biol Markers; 2019 Dec; 34(4):373-380. PubMed ID: 31608800
[TBL] [Abstract][Full Text] [Related]
19. The expression of MUC mucin in cholangiocarcinoma.
Mall AS; Tyler MG; Ho SB; Krige JE; Kahn D; Spearman W; Myer L; Govender D
Pathol Res Pract; 2010 Dec; 206(12):805-9. PubMed ID: 20947262
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Elevated Pre-treatment Serum CA-125 in Epithelial Ovarian Cancer: A Meta-Analysis.
Wang Q; Feng X; Liu X; Zhu S
Front Oncol; 2022; 12():868061. PubMed ID: 35463345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
